Trial intelligence / Profile preview

Nefopam for Pain in Orthopedic Surgery with Tourniquet

NCT06680609Phase 1Completed

Sponsor
King Abdullah University Hospital
Start
Jun 2023
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in postoperative pain comparing Nefopam with Placebo (2 arms). Primary endpoint: Severity of pain at the site of surgery and tourniquet insertion. Started Jun 2023; status: completed.

02

Drugs

nefopam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06680609.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06680609.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call